Literature DB >> 25670374

Clinical Pharmacology & Therapeutics: the next five years.

S A Waldman1, A Terzic.   

Abstract

It has been nearly ten years since we joined the editorial organization of Clinical Pharmacology & Therapeutics (CPT), as part of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) family. During that tenure, the primary mandate has been the growth of CPT, recognized as one of the key voices of the discipline and the Society. Set goals were realized in concert with a strong editorial team, a diverse editorial board, a dedicated editorial staff, and outstanding authors, leveraging a leading publishing infrastructure and responding to the needs of a global readership, expanding membership, and the discipline as a whole. The impending decade anniversary, and the transition to a new publisher, offers a natural juncture to reflect on progress, and chart plans for the future of the Journal.
© 2014 ASCPT.

Entities:  

Mesh:

Year:  2014        PMID: 25670374      PMCID: PMC5538564          DOI: 10.1002/cpt.22

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

Review 1.  Anti-interleukin therapy in asthma.

Authors:  R M Dunn; M E Wechsler
Journal:  Clin Pharmacol Ther       Date:  2014-12-15       Impact factor: 6.875

Review 2.  Advances, nuances, and potential pitfalls when exploiting the therapeutic potential of RNA interference.

Authors:  M Battistella; P A Marsden
Journal:  Clin Pharmacol Ther       Date:  2015-01       Impact factor: 6.875

Review 3.  FDA designations for therapeutics and their impact on drug development and regulatory review outcomes.

Authors:  A S Kesselheim; J J Darrow
Journal:  Clin Pharmacol Ther       Date:  2014-12-01       Impact factor: 6.875

Review 4.  Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Authors:  A Dasgupta; L Bowman; C L D'Arsigny; S L Archer
Journal:  Clin Pharmacol Ther       Date:  2014-11-28       Impact factor: 6.875

Review 5.  Helicase-primase as a target of new therapies for herpes simplex virus infections.

Authors:  S H James; K B Larson; E P Acosta; M N Prichard
Journal:  Clin Pharmacol Ther       Date:  2014-11-18       Impact factor: 6.875

Review 6.  Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.

Authors:  K Venkatakrishnan; L E Friberg; D Ouellet; J T Mettetal; A Stein; I F Trocóniz; R Bruno; N Mehrotra; J Gobburu; D R Mould
Journal:  Clin Pharmacol Ther       Date:  2014-12-09       Impact factor: 6.875

  6 in total
  3 in total

1.  Clinical Pharmacology & Therapeutics: Past, Present, and Future.

Authors:  S A Waldman; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2017-03       Impact factor: 6.875

2.  Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics.

Authors:  S A Waldman; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2017-09       Impact factor: 6.875

3.  Developing and Using Therapeutics for Emerging Infections.

Authors:  Jeannine S McCune; Kellie S Reynolds
Journal:  Clin Pharmacol Ther       Date:  2015-10       Impact factor: 6.875

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.